Dr. Haoming (Carl) Qiu is a radiation oncologist at the University of Rochester Medical Center seeing patients at both Wilmot Cancer Center in Rochester and Sands Cancer Center in Canandaigua. Dr. Qiu received his medical education at the Johns Hopkins University School of Medicine in Baltimore, MD and completed his residency in radiation oncology at the University of Rochester Medical Center. Dr. Qiu brings a high level of technical expertise along with a friendly and optimistic attitude in caring for his patients.

In addition to external beam radiation, Dr. Qiu also treats patient with the following radiopharmaceutical therapies.

1.Lutathera (lutetium Lu 177 dotatate) PRRT (Peptide Receptor Radionuclide Therapy) for patients with neuroendocrine tumors
2. Pluvicto (lutetium Lu 177 PSMA-617) for patients with prostate cancer
3. Therasphere (Y90) radioembolization for patients with liver cancers.

If you are interested in a consultation, please have your doctor call our office for a referral. (585) 275-5625.

Certified Specialties

Radiation Oncology - American Board of Radiology

Faculty Appointments

Associate Professor - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, University of Rochester Medical Center. 2013 - 2016

Residency, Radiation Oncology, Loyola University Medical Center. 2012 - 2013

Internship, Internal Medicine, Sinai Hospital Of Baltimore. 2011 - 2012

Education

MD | Johns Hopkins University. 2011

Awards

Roentgen Resident/Fellow Research Award. 2015

Excellence in Medical Student Research. 2011

Research

Dr. Qiu's research focuses on the use of radiation therapy in the treatment of gastrointestinal, lung and prostate cancers. He is also interested in the use of theranostics and radiopharmaceuticals for the treatment of malignant conditions. Please see below for a number of clinical trials that Dr. Q...

Clinical Trials

A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)

Lead Researcher: Haoming Qiu

This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients wh...

Publications

Journal Articles

Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy

Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA.

Clin Cancer Res. 2022; 28(1): 150-162.

Anterior mediastinal large cell neuroendocrine carcinoma with elevated AFP: A case report and review.

Komisarof J, Qiu H, Velez MJ, Mulford D

Molecular and clinical oncology.. 2021 February 14 (2):34. Epub 12/22/2020.

Co-administration of a clinically relevant dexamethasone dosage with ablative radiotherapy reduces peripheral lymphocytes but does not alter in vivo intratumoral lymphocyte phenotype or inhibit efficacy of radiotherapy in a murine colorectal tumor model.

Battaglia NG; Uccello TP; Hughson A; Garrett-Larsen J; Caldon JJ; Qiu H; Gerber SA; Lord EM.

International journal of radiation oncology, biology, physics. 2021; 111(1): 284-296.

Development of an orthotopic murine model of rectal cancer in conjunction with targeted short-course radiation therapy

Uccello TP; Kintzel SA; Mills BN; Murphy JD; Garrett-Larsen J; Battaglia NG; Rodriguez CJ; Drage MG; Ye J; Love TMT; Johnston CJ; Repasky EA; Qiu H; Linehan DC; Lord EM; Gerber SA.

Adv Radiat Oncol. 2021; 7(2): 100867.

Milano MT; Bates JE; Budnik J; Qiu H; Hardy S; Cummings MA; Baumgart MA; Maggiore RJ; Mulford DA; Usuki KY.

Risk of brain metastases in T1–3N0 NSCLC: a

Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints.

Milano MT, Mihai A, Kang J, Singh DP, Verma V, Qiu H, Chen Y, Kong FS

Expert review of anticancer therapy.. 2019 November 19 (11):959-969. Epub 11/05/2019.

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment.

Mills BN, Connolly KA, Ye J, Murphy JD, Uccello TP, Han BJ, Zhao T, Drage MG, Murthy A, Qiu H, Patel A, Figueroa NM, Johnston CJ, Prieto PA, Egilmez NK, Belt BA, Lord EM, Linehan DC, Gerber SA

Cell reports.. 2019 October 829 (2):406-421.e5. Epub 1900 01 01.

Stereotactic body radiation therapy versus metastasectomy for oligometastases.

Qiu H, Katz AW, Milano MT

Journal of thoracic disease.. 2019 April 11 (4):1082-1084. Epub 1900 01 01.

SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.

Qiu H, Moravan MJ, Milano MT, Usuki KY, Katz AW

Journal of gastrointestinal cancer.. 2018 December 49 (4):463-469. Epub 1900 01 01.

Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.

Qiu H, Katz AW, Chowdhry AK, Usuki KY, Singh DP, Metcalfe S, Cheruvu P, Chen Y, Okunieff P, Milano MT

American journal of clinical oncology.. 2018 January 41 (1):53-58. Epub 1900 01 01.

Oligometastases to the liver: predicting outcomes based upon radiation sensitivity.

Qiu H, Katz AW, Milano MT

Journal of thoracic disease.. 2016 October 8 (10):E1384-E1386. Epub 1900 01 01.

Maxillary and mandible contouring in patients with a head and neck area irradiation.

Rouers M, Antoni D, Thompson A, Truntzer P, Haoming QC, Bourrier C, Meyer P, Dubourg S, Ganansia V, Guihard S, Bornert F, Noel G

Practical radiation oncology.. 2016 6 (3):e61-e72. Epub 10/09/2015.

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma.

Mohamed M, Katz AW, Tejani MA, Sharma AK, Kashyap R, Noel MS, Qiu H, Hezel AF, Ramaraju GA, Dokus MK, Orloff MS

Advances in radiation oncology.. 2016 1 (1):35-42. Epub 12/29/2015.

A case report of long-term survival of metastatic extraskeletal myxoid chondrosarcoma treated with surgery and hypofractionated radiotherapy

Qiu H; Hare M; Chen Y.

J Radiother Pract. 2014; 13: 493-497.

Comparison of conventional and 3-dimensional computed tomography against histopathologic examination in determining pancreatic adenocarcinoma tumor size: implications for radiation therapy planning.

Qiu H, Wild AT, Wang H, Fishman EK, Hruban RH, Laheru DA, Kumar R, Hacker-Prietz A, Tuli R, Tryggestad E, Schulick RD, Cameron JL, Edil BH, Pawlik TM, Wolfgang CL, Herman JM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2012 August 104 (2):167-72. Epub 08/08/2012.

Clinicopathologic Comparison of High-Dose-Rate Endorectal Brachytherapy versus Conventional Chemoradiotherapy in the Neoadjuvant Setting for Resectable Stages II and III Low Rectal Cancer.

Smith JA, Wild AT, Singhi A, Raman SP, Qiu H, Kumar R, Hacker-Prietz A, Hruban RH, Kamel IR, Efron J, Wick EC, Azad NS, Diaz LA, Le Y, Armour EP, Gearhart SL, Herman JM

International journal of surgical oncology.. 2012 2012 :406568. Epub 07/08/2012.

Neoadjuvant chemoradiation followed by interstitial prostate brachytherapy for synchronous prostate and rectal cancer.

Qiu H, Herman JM, Ahuja N, Deweese TL, Song DY

Practical radiation oncology.. 2012 2 (4):e77-e84. Epub 11/30/2011.

Outbreak management and implications of a nosocomial norovirus outbreak.

Johnston CP, Qiu H, Ticehurst JR, Dickson C, Rosenbaum P, Lawson P, Stokes AB, Lowenstein CJ, Kaminsky M, Cosgrove SE, Green KY, Perl TM

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.. 2007 September 145 (5):534-40. Epub 07/18/2007.

Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy

Bradley Mills, Haoming Qiu, Michael Drage, Chunmo Chen, Jocelyn Mathew, Jesse Garrett-Larsen, Jian Ye, Taylor Uccello, Joseph Murphy, Brian Belt, Edith Lord, Alan Katz, David Linehan, and Scott Gerber.

Clinical Cancer Research. .

Books

Medical Radiology: Radiation Oncology: Advances in Radiation Oncology in Lung Cancer (2021)

Chapter: Oligometastatic Disease – Basic Aspects and Clinical Results

Authors: Sakthivel G, Singh DP, Qiu H, Milano MT

Publisher: Springer 2021

Medical Radiology: Radiation Oncology: Advances in Radiation Oncology in Lung Cancer (2021)

Chapter: Programed Death Receptor-1 (PD-1)

Authors: Qiu H, Chen Y

Publisher: Springer, New York 2021

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

5.0

During this visit, did this provider show respect for what you had to say?

5.0

During this visit did this provider give you easy to understand information about these health questions or concerns?

4.9

During this visit, did this provider listen carefully to you?

4.9

During this visit, did this provider explain things in a way that was easy to understand?

4.9

Patient Comments

Doctor explained very clearly the treatment I will be receiving.

Dec 29, 2023

5.0

Provider was caring, compassionate and interested in my questions and concerns, also of my wife's questions & concerns.

Aug 09, 2023

5.0

Dr. Qiu took charge of my situation and made things happen!

Jul 25, 2023

Great team and great provider!

May 16, 2023

5.0

A+

May 09, 2023

5.0

I have Dr. Qui And Dr Valencia they are great Drs. I like them and their help immensely.

Mar 16, 2023

5.0

Dr Q listens to me, always asks if I have questions, and answered them. He is very kind and caring.

Oct 25, 2022

Dr. Qiu was very helpful and positive regarding my health.

Oct 20, 2022

5.0

Highest regards and recommendations a real credit to your facility.

Sep 08, 2022

5.0

My dr. gave me excellent care from start to finish!

Feb 17, 2022